The 11 references in paper V. Gorbunova A., E. Pigarova A., L. Rozhinskaya Ya., I. Voronkova A., Yu. Krupinova A., G. Emel’yanova S., L. Kruglova S., S. Shiryaev V., M. Dolgushin B., M. Bilik E., E. Kobyakova A., D. Komov V., В. Горбунова А., Е. Пигарова А., Л. Рожинская Я., И. Воронкова А., Ю. Крупинова А., Г. Емельянова С., Л. Круглова С., С. Ширяев В., М. Долгушин Б., М. Билик Е., Е. Кобякова А., Д. Комов В. (2017) “ПРИМЕНЕНИЕ СОРАФЕНИБА (НЕКСАВАРА) В ЛЕЧЕНИИ БОЛЬНОЙ ДИССЕМИНИРОВАННЫМ РАКОМ ПАРАЩИТОВИДНЫХ ЖЕЛЕЗ (КЛИНИЧЕСКИЙ СЛУЧАЙ) // THE USE OF SORAFENIB (NEXAVAR) IN TREATMENT OF PATIENT WITH DISSEMINATED PARATHYROID CANCER: A CASE REPORT” / spz:neicon:ogsh:y:2016:i:4:p:67-72

1
Schantz A., Castleman B. Parathyroid carcinoma. A study of 70 cases. Cancer 1973;31:600–5.
(check this in PDF content)
2
Handahl S.A., Fleming I.D., Fremgen A.M. et al. Two hundred eighty-six cases of parathyroid carcinoma treated in the U.S. between 1985–1995: a National Cancer Data Base Report. The American College of Surgeons Commission on Cancer and the American Cancer Society. Cancer 1999;86:538–44.
(check this in PDF content)
3
Okamoto T. Parathyroid carcinoma: etiology, diagnosis, and treatment. World J Surg 2009;33(11):2343–54.
(check this in PDF content)
4
Рожинская Л.Я., Мокрышева Н.Г., Кузнецов Н.С. Алгоритмы обследования и лечения пациентов в эндокринологии. Методические рекомендации ФГУ «Эндокринологический научный центр». М., 2009. [Rozhinskaya L.Ya., Mokrysheva N.G., Kuznetsov N.S. Algorithms of examination and treatment of patients in endocrinology. Methodical recommendations of the FSI “Endocrinological research center”. Moscow, 2009. (In Russ.)].
(check this in PDF content)
5
Мокрышева Н.Г. Первичный гиперпаратиреоз: современное представление о проблеме. Лечение и профилактика 2013;2(6):143–52. [Mokrysheva N.G. Primary hyperparathyroidism: a modern view of the issue. Lechenie i profilaktika = Treat ment and Prevention 2013;2(6):143–52. (In Russ.)].
(check this in PDF content)
6
Bilezikian J.P., Potts J.T., Fuleihan G.-H. et al. Summary Statement from a Workshop on Asymptomatic Primary Hyperparathyroidism: A Perspective for the 21st Century. J Bone Miner Res 2002;17 Suppl 2:N2–11.
(check this in PDF content)
7
Древаль А.В., Тевосян Л.Х. Первичный гиперпаратиреоз. Русский медицинский журнал 2015;(8):427. [Dreval’ A.V., Tevosyan L.Kh. Primary hyperparathyroidism. Russkiy meditsinskiy zhurnal = Russian Medical Journal 2015;(8):427. (In Russ.)].
(check this in PDF content)
8
Agarwal G., Dhingra S., Mishra S., Langenbecks K.N. Implantation of parathyroid carcinoma along fine needle aspiration track. Arch Surg 2006;391(6):623–6.
(check this in PDF content)
9
Spinelli C., Bonadio A., Berti P. et al. Cutaneous spreading of parathyroid carcinoma after fine needle aspiration cytology. J Endocrinol Inv 2000;23(4):255–7.
(check this in PDF content)
10
Brose M.S., Nutting C.M., Jarzab B. et al. Sorafenib in radioactive iodine-refractory, locally advanced or metastatic differentiated thyroid cancer: a randomised, double-blind, phase 3 trial. Lancet 2014;384(9940):319–28. DOI: 10.1016/S0140-6736(14)60421-9.
(check this in PDF content)
11
Schlumberger M., Tahara M., Wirth L.J. et al. Lenvatinib versus placebo in radioiodine-refractory thyroid cancer. N Engl J Med 2015;372(7):621–30. DOI: 10.1056/NEJMoa1406470.
(check this in PDF content)